Photodynamic therapy for steroid-associated central serous chorioretinopathy

British Journal of Ophthalmology

Volumn 95, Issue 4, 2011, Pages 518-523

  Lee, Tae Gon ^a,b   Kim, Judy E ^a  

^a EYE INSTITUTE   (United States)

^b Konyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; VERTEPORFIN;

ADULT; AGED; ARTICLE; ASTHMA; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DERMATITIS; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INTERMITTENT THERAPY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RETINA DETACHMENT; RETREATMENT; SHORT COURSE THERAPY; SINUSITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; TREATMENT DURATION; VISUAL ACUITY;

ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 79952915888     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.181149     Document Type: Article

References (34)

1. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63(Suppl):1-139.
2. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 1987;7:111-31. (Pubitemid 17136150)
3. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989;96:854-9. (Pubitemid 19165113)
4. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina 2002;22:19-24. (Pubitemid 41070746)
5. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. Retina 2003;23:288-98. (Pubitemid 36792972)
6. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995;79:922-5.
7. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984;68:329-31. (Pubitemid 15118321)
8. Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997;104:1653-60. (Pubitemid 28053467)
9. Garg SP, Dada T, Talwar D, et al. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962-4. (Pubitemid 27493982)
10. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy. Arch Ophthalmol 1993;111:1229-33.
11. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834-7.
12. Koyama M, Mizota A, Igarashi Y, et al. Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy. Ophthalmologica 2004;218:107-10. (Pubitemid 38338473)
13. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003;23:235-7. (Pubitemid 36548818)
14. Canakis C, Livir-Rallatos C, Panayiotis Z, et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic chronic central serous chorioretinopathy. Am J Ophthalmol 2003;136:750-2. (Pubitemid 37153200)
15. Cardillo Piccolino F, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-63. (Pubitemid 38040573)
16. Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-8. (Pubitemid 38010546)
17. Taban M, Boyer DS, Thomas EL, et al. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004;137:1073-80. (Pubitemid 38759356)
18. Ober MD, Yannuzzi LA, DO DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005;112:2088-94. (Pubitemid 41720985)
19. Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008;28:85-93.
20. Reibaldi M, Boscia F, Avitabile T, et al. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy. Eur J Ophthalmol 2009;19:154-8.
21. Moon JW, Yu HG, Kim TW, et al. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009;247:1315-23.
22. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2009;149:307-15.
23. Ruiz-Moreno JM, Lugo FL, Armada F, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmol 2009;88:371-6.
24. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999;117:1329-45.
25. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-42. (Pubitemid 24308054)
26. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203-13. (Pubitemid 26190849)
27. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34. (Pubitemid 26026078)
28. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986;224:321-4. (Pubitemid 16113162)
29. Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988;226:548-52.
30. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431-48. (Pubitemid 35341618)
31. Spraul CW, Lang GE, Lang GK. Central serous chorioretinopathy in systemic therapy with corticosteroids. Ophthalmologe 1997;94:392-6. (Pubitemid 27299676)
32. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997;41:180-5. (Pubitemid 27331358)
33. Lee PY, Kim KS, Lee WK. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol 2009;53:52-6.
34. Torres-Soriano ME, Garcia-Aguirre G, Kon-Jara V, et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 2008;246:1235-9.